Abstract | INTRODUCTION: PATIENTS AND METHOD: RESULTS: There was a significant (P<0.0001) decrease of pain, an increased mouth opening, and diduction at three months. Seventy percent of the patients felt less muscle tenderness. The patient felt his psychological state had improved and so did his family. DISCUSSION:
|
Authors | C Denglehem, J-M Maes, G Raoul, J Ferri |
Journal | Revue de stomatologie et de chirurgie maxillo-faciale
(Rev Stomatol Chir Maxillofac)
Vol. 113
Issue 1
Pg. 27-31
(Feb 2012)
ISSN: 1776-257X [Electronic] France |
Vernacular Title | Toxine botulinique de type A : traitement antalgique des dysfonctions de l'appareil manducateur. |
PMID | 22240328
(Publication Type: Clinical Trial, Journal Article)
|
Copyright | Copyright © 2012 Elsevier Masson SAS. All rights reserved. |
Chemical References |
- Analgesics
- Botulinum Toxins, Type A
|
Topics |
- Adolescent
- Adult
- Aged
- Analgesia
(methods)
- Analgesics
(therapeutic use)
- Botulinum Toxins, Type A
(therapeutic use)
- Female
- Humans
- Male
- Middle Aged
- Pain
(drug therapy, epidemiology)
- Pain Measurement
- Temporomandibular Joint Disorders
(complications, drug therapy, epidemiology)
- Young Adult
|